| Sjögren’s syndrome CP Mavragani, GE Fragoulis, HM Moutsopoulos The Autoimmune Diseases, 495-510, 2014 | 462 | 2014 |
| The geoepidemiology of Sjögren's syndrome CP Mavragani, HM Moutsopoulos Autoimmunity reviews 9 (5), A305-A310, 2010 | 394 | 2010 |
| A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies M Dastmalchi, C Grundtman, H Alexanderson, CP Mavragani, ... Annals of the rheumatic diseases 67 (12), 1670-1677, 2008 | 283 | 2008 |
| Type I and II interferon signatures in Sjogren's syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis A Nezos, F Gravani, A Tassidou, EK Kapsogeorgou, M Voulgarelis, ... Journal of autoimmunity 63, 47-58, 2015 | 255 | 2015 |
| Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use S Fragkioudaki, CP Mavragani, HM Moutsopoulos Medicine 95 (25), e3766, 2016 | 223 | 2016 |
| Augmented interferon‐α pathway activation in patients with Sjögren's syndrome treated with etanercept CP Mavragani, TB Niewold, NM Moutsopoulos, SR Pillemer, SM Wahl, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 183 | 2007 |
| Activation of the type I interferon pathway in primary Sjogren’s syndrome CP Mavragani, MK Crow Journal of autoimmunity 35 (3), 225-231, 2010 | 182 | 2010 |
| Cardiovascular disease in systemic lupus erythematosus: a comprehensive update M Giannelou, CP Mavragani Journal of autoimmunity 82, 1-12, 2017 | 178 | 2017 |
| Central nervous system involvement in Sjögren’s syndrome FC Soliotis, CP Mavragani, HM Moutsopoulos Annals of the rheumatic diseases 63 (6), 616-620, 2004 | 167 | 2004 |
| Management of Sjögren’s Syndrome CP Mavragani, MN Manoussakis Sjögren's Syndrome, 35-45, 2016 | 165 | 2016 |
| Expression of long interspersed nuclear element 1 retroelements and induction of type I interferon in patients with systemic autoimmune disease CP Mavragani, I Sagalovskiy, Q Guo, A Nezos, EK Kapsogeorgou, P Lu, ... Arthritis & rheumatology 68 (11), 2686-2696, 2016 | 159 | 2016 |
| B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome A Nezos, A Papageorgiou, G Fragoulis, D Ioakeimidis, M Koutsilieris, ... Journal of autoimmunity 51, 89-98, 2014 | 130 | 2014 |
| Sjögren's syndrome: old and new therapeutic targets CP Mavragani, HM Moutsopoulos Journal of autoimmunity 110, 102364, 2020 | 129 | 2020 |
| Predicting the outcome of Sjogren’s syndrome-associated non-hodgkin’s lymphoma patients A Papageorgiou, DC Ziogas, CP Mavragani, E Zintzaras, AG Tzioufas, ... PloS one 10 (2), e0116189, 2015 | 118 | 2015 |
| Conventional therapy of Sjogren’s syndrome CP Mavragani, HM Moutsopoulos Clinical reviews in allergy & immunology 32, 284-291, 2007 | 106 | 2007 |
| Endocrine alterations in primary Sjogren's syndrome: an overview CP Mavragani, GE Fragoulis, HM Moutsopoulos Journal of autoimmunity 39 (4), 354-358, 2012 | 100 | 2012 |
| Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations F Gravani, I Papadaki, E Antypa, A Nezos, K Masselou, D Ioakeimidis, ... Arthritis research & therapy 17, 1-13, 2015 | 99 | 2015 |
| Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon‐β/α ratios in rheumatoid arthritis patients: a post hoc … CP Mavragani, DT La, W Stohl, MK Crow Arthritis & Rheumatism: Official Journal of the American College of …, 2010 | 99 | 2010 |
| Fatigue in primary Sjögren's syndrome: clinical, laboratory, psychometric, and biologic associations T Karageorgas, S Fragioudaki, A Nezos, D Karaiskos, HM Moutsopoulos, ... Arthritis care & research 68 (1), 123-131, 2016 | 91 | 2016 |
| Stress, coping strategies and social support in patients with primary Sjögren’s syndrome prior to disease onset: a retrospective case–control study D Karaiskos, CP Mavragani, S Makaroni, E Zinzaras, M Voulgarelis, ... Annals of the rheumatic diseases 68 (1), 40-46, 2009 | 91 | 2009 |
